Canadian Rheumatology Today

Articles

• 

  IL-17 Inhibition vs IL-23 Inhibition for Psoriatic Arthritis: An Ongoing Debate

  Pankti Mehta, MD, Vinod Chandran, MD, MBBS, DM, PhD, FRCPC

  4–14

  • PDF (en)
• 

  Can We Prevent Psoriatic Arthritis?

  Alexandra Kobza, MD, FRCPC

  16–21

  • PDF (en)
• 

  Idiopathic Inflammatory Myopathy-Associated Cancer: A Review of Risk Factors and Screening Recommendations

  Eugene Krustev, MD

  22–31

  • PDF (en)
• 

  What Can We Tell Our Patients About Rheumatoid Arthritis Risk?

  Liam O’Neil, MD, MHSc, FRCPC, Hani El-Gabalawy, MD, FRCPC

  32–35

  • PDF (en)